Paris shooting: 1 cop killed, IS names attacker as Al-Belgiki

April 21, 2017

Paris, Apr 21: A French policeman was shot dead and two others were wounded in central Paris on Thursday night in an attack carried out days before presidential elections and quickly claimed by the Islamic State militant group.

paris

President Francois Hollande said he was convinced the "cowardly killing" on the Champs Elysees boulevard, in which the assailant was shot dead by police, was an act of terrorism.

The wide avenue that leads away from the Arc de Triomphe had been crowded with Parisians and tourists enjoying a spring evening, but police quickly cleared the area, which remained empty well into the night of all but heavily armed security forces and police vehicles.

Paris Prosecutor Francois Molins said the man had been identified, but investigators were still assessing if he had accomplices.

A police arrest warrant issued earlier on Thursday, which was seen by Reuters after the attack, warned of a dangerous individual who had come into France by train from Belgium on Thursday. It was unclear if that man was the attacker or linked to the shooting.

Officers searched the home of the dead attacker in a town east of Paris, a police source said.

"The sense of duty of our policemen tonight averted a massacre ... they prevented a bloodbath on the Champs Elysees," Interior Minister Matthias Fekl told reporters.

"A little after 9 PM a vehicle stopped alongside a police car which was parked. Immediately a man got out and fired on the police vehicle, mortally wounding a police officer," Interior Ministry spokesman Pierre-Henry Brandet said.

France has lived under a state of emergency since 2015 and has suffered a spate of Islamist militant attacks mostly perpetrated by young men who grew up in France and Belgium and that have killed more than 230 people in the past two years.

Witness Chelloug, a kitchen assistant, told Reuters he was walking out of a shop and saw a man get out of a car and open fire with a rifle on a policeman. "The policeman fell down. I heard six shots, I was afraid. I have a two year-old girl and I thought I was going to die... He shot straight at the police officer."

The Islamic State group, which is being driven out of its areas of territorial control in Iraq and Syria by Western-backed coalitions and has hundreds of French-speaking fighters, claimed responsibility for Thursday's shooting via its Amaq news agency, naming the attacker as Abu Yousif al-Belgiki.

The claim came quickly and the naming of the assailant suggested a degree of direct contact with Islamic State. The group also claimed responsibility for a car attack in London last month killing four, but gave no name or details.

Police sources said the man was known to intelligence services. French television networks reported that he was a 39-year-old French national known for previous violent crimes.

Police Clear the Area

Police authorities called on the public to avoid the area.

The Arc de Triomphe monument and the top half of the Champs Elysees were packed with police vans, lights flashing and heavily armed police shutting the area down after what was described by one journalist as a major exchange of fire.

The incident came as French voters prepared go to the polls on Sunday in the most tightly-contested presidential election in decades.

"We shall be of the utmost vigilance, especially in relation to the election," said President Hollande, who is not himself running for re-election.

Earlier this week, two men were arrested in Marseille who police said had been planning an attack ahead of the election.

A machine gun, two hand guns and three kilos of TATP explosive were among the weapons found at a flat in the southern city along with Islamic State propaganda materials, according to Molins.

That incident brought issues of security and immigration back to the forefront of the campaign, with the anti-immigration National Front leader Marine Le Pen repeating her call for Europe's partly open borders to be closed.

On Thursday, speaking after a television appearance, she said she was "deeply angry" as well as sad for the police victims "because not everything is done ... to protect our compatriots. They need more than our compassion."

Candidates in the election said they had been warned about the Marseille attackers. Francois Fillon, who is the conservative candidate, said he would cancel the campaign events he had been planning for Friday.

He also called for campaigning generally to be suspended, although from midnight on Friday the law says it has to stop anyway. Far left candidate Jean-Luc Melenchon said campaigning should continue. In November, 2015, Paris was rocked by near simultaneous gun-and-bomb attacks on entertainment sites, in which 130 people died and 368 were wounded. Islamic State claimed responsibility. Two of the 10 known perpetrators were Belgian citizens and three others were French.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 6,2020

Islamabad, Jun 6: Pakistan has reported a record 97 COVID-19 deaths in a single day, taking the total number of fatalities to 1,935, while the number of confirmed cases in the country approached 94,000 after over 4,700 infections were detected, the health ministry said on Saturday.

Punjab registered 35,308 COVID-19 cases, Sindh 34,889, Khyber-Pakhtunkhwa 12,459, Balochistan 5,776 Islamabad 4,323, Gilgit-Baltistan 897 and Pakistan-occupied Kashmir 331 cases, the Ministry of National Health Services said.

The total number of COVID-19 cases reached 93,983 after 4,734 new infections were detected across the country, it said.

With a record 97 fatalities in one day, the death toll in the country has reached 1,935, while 32,581 people have recovered from the disease.

The ministry said that the total number of active COVID-19 cases in Pakistan are 59,467, out of which 1,265 patients are in critical condition.

More than 100 labs in the country have so far conducted 660,508 tests, including 22,185 in the last 24 hours.

There are 747 hospitals across the country with COVID-19 treatment facilities where 5,060 patients are being treated. Others have been asked to self-isolate at home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 11,2020

New York, Jan 11: The United Nations Security Council (UNSC) on Friday renewed a six-year-long cross-border humanitarian aid deliveries mechanism into Syria.

According to Sputnik, the Security Council voted in favour of a resolution on Friday that allows cross border deliveries to be conducted via Turkey, preserving two checkpoints and excluding the Al-Yarubiyah border crossing with Iraq and the Al-Ramtha crossing with Jordan, until July 10, 2020.

Russia proposed to amend the adopted resolution by replacing a part of the draft which stipulates that humanitarian assistance into Syria should be delivered based on the principles of humanity, neutrality, impartiality and independence by the phrase that such aid should be provided "in accordance with the guiding principles of humanitarian emergency assistance, as contained in UNGA resolution 46/182."

The agreement was reached after Belgium and Germany decided to amend the original version of their joint resolution, which proposed keeping three points for cross-border deliveries into the Arab republic.

In December last year, the United Nations had said that over 235,000 people fled the Idlib region in the last two weeks after Russia and Syria launched airstrikes in a bid to take over the last major opposition bastion.

Russia backed Syria government launched a fresh assault to capture the province.

Syrian Bashar al-Assad regime, backed by Iran, has reportedly promised to take back the rebel-controlled area and broke a ceasefire that was announced in August.

They have since December 19 seized dozens of towns and villages from armed fighters amid clashes that have killed hundreds on both sides.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.